Logo Logo
Hilfe
Hilfe
Switch Language to English

Lechner, B.; Heinrich, D.; Noelting, S.; Osswald-Kopp, A.; Rubinstein, G.; Sauerbeck, J.; Beuschlein, F. und Reincke, M. (2018): Update endokrine Hypertonie. In: Internist, Bd. 59, Nr. 11: S. 1163-1179

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Endocrine disorders are the most common causes of secondary hypertension. Early diagnosis and specific treatment are crucial for improvement of the prognosis. This article provides an overview on which clinical constellations point to an increased risk of secondary causes of hypertension. These include spontaneous hypokalemia, young age at onset of hypertension, adrenal incidentaloma and therapy refractive arterial hypertension. The basic diagnostics include determination of the aldosterone to renin ratio, measurement of free plasma metanephrines and a1mg dexamethasone suppression test. Borderline results require repeated control testing and/or confirmatory testing under standardized test conditions. In cases of repeatedly conspicuous results referral to aspecialized clinic should be considered for further clarification and confirmation of the diagnosis. Imaging diagnostics may constitute an adjunct to laboratory testing after the diagnosis has been confirmed. Therapeutic algorithms vary depending on the underlying endocrine disease.

Dokument bearbeiten Dokument bearbeiten